| On Insider
Trading Charges Former FBI Trainee Markin
Has Until Nov 10 To Propose Motions
By Matthew
Russell Lee, Patreon Maxwell
Book
BBC -
Honduras
- CIA
Trial Book - NY
Mag
SDNY COURTHOUSE,
Oct 20 – Seth Markin was the
subject of an insider trading
press conference on July 25,
2022. Then for his presentment
he got a taxpayer-funded
lawyer, declaring himself
eligible in a still-sealed CJA
23 financial affidavit.
On July
25, U.S. District Court for
the Southern District of New
York Magistrate Sarah Netburn
approved and sealed his
Criminal Justice Act 23
affidavit. Inner City Press
has previously gotten unsealed
the CJA 23's of Michael
Avenatti, and Honduras alleged
narco trafficker Tigre
Bonilla. But others' keep
getting sealed.
On August 10,
Markin ponied up and retained
Maurice Sercarz, who
previously represented among
others horse drugging
defendant Seth Fishman:
"NOTICE OF ATTORNEY
APPEARANCE: Maurice H. Sercarz
appearing for Seth Markin.
Appearance Type: Retained.
(Sercarz, Maurice)."
On October 20,
Judge Ramos held a proceeding
and ruled, "Markin shall
submit a letter advising the
court whether or not he
intends to file pretrial
motions, and if so, provide a
proposed briefing schedule by
November 10, 2022. Curcio
Hearing held as to Brandon
Wong. Speedy trial time is
excluded from today, October
20, 2022, until January 20,
2023, in the interests of
justice. Defendants bail
continued.
Markin is
free on a $200,000 bond, with
a taxpayer funded lawyer. The
prosecutors said:
What kind
of insider trader big enough
for an SDNY press conference
is, on the same day, declared
eligible for publicly-paid
counsel?
A first
proceeding before Judge Ramos
was set: "NOTICE OF HEARING as
to Seth Markin, Brandon Wong.
An initial conference will be
held on August 3, 2022 at
11:00 a.m. before the Hon.
Edgardo Ramos."
In early
2021, SETH MARKIN and BRANDON
WONG together made more than
$1.4 million dollars in
illegal profits by trading in
stock based on inside
information that MARKIN
misappropriated from his
then-girlfriend, who was then
an attorney at a major law
firm in Washington D.C.
assigned to work on the
acquisition of Pandion
Therapeutics (“Pandion”) by
Merck & Co. (“Merck”).
The case is US v.
Markin, et al., 22-cr-395
(Ramos)
***
Your support means a lot. As little as $5 a
month helps keep us going and grants you
access to exclusive bonus material on our
Patreon page. Click
here to become a patron.
Feedback:
Editorial [at] innercitypress.com
SDNY Press Room 480, front cubicle
500 Pearl Street, NY NY 10007 USA
Mail: Box 20047, Dag
Hammarskjold Station NY NY 10017
Reporter's mobile (and weekends):
718-716-3540
Other, earlier Inner City Press are
listed here,
and some are available in the ProQuest
service, and now on Lexis-Nexis.
Copyright 2006-2022 Inner City
Press, Inc. To request reprint or other
permission, e-contact Editorial [at]
innercitypress.com
|
,
